Vyvgart®

Vyvgart® (efgartigimod alfa-fcab) is a FDA-approved treatment that uses a fragment of an IgG antibody to treat adults with anti-AChR antibody positive generalized myasthenia gravis (gMG).

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

Vyvgart® Referral Form